These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 32691965)
1. Antihypertensive activity and molecular interactions of irbesartan in complex with 2-hydroxypropyl-β-cyclodextrin. Leonis G; Christodoulou E; Ntountaniotis D; Chatziathanasiadou MV; Mavromoustakos T; Naziris N; Chountoulesi M; Demetzos C; Valsami G; Damalas DE; Tzakos AG; Thomaidis NS; Karageorgos V; Liapakis G Chem Biol Drug Des; 2020 Jul; 96(1):668-683. PubMed ID: 32691965 [TBL] [Abstract][Full Text] [Related]
2. Exploring the interactions of irbesartan and irbesartan-2-hydroxypropyl-β-cyclodextrin complex with model membranes. Liossi ΑS; Ntountaniotis D; Kellici TF; Chatziathanasiadou MV; Megariotis G; Mania M; Becker-Baldus J; Kriechbaum M; Krajnc A; Christodoulou E; Glaubitz C; Rappolt M; Amenitsch H; Mali G; Theodorou DN; Valsami G; Pitsikalis M; Iatrou H; Tzakos AG; Mavromoustakos T Biochim Biophys Acta Biomembr; 2017 Jun; 1859(6):1089-1098. PubMed ID: 28274845 [TBL] [Abstract][Full Text] [Related]
3. Hydroxypropyl-β-cyclodextrin functionalized calcium carbonate microparticles as a potential carrier for enhancing oral delivery of water-insoluble drugs. Zhang L; Zhu W; Lin Q; Han J; Jiang L; Zhang Y Int J Nanomedicine; 2015; 10():3291-302. PubMed ID: 25995635 [TBL] [Abstract][Full Text] [Related]
4. Losartan Interactions with 2-Hydroxypropyl-β-CD. Palli V; Leonis G; Zoupanou N; Georgiou N; Chountoulesi M; Naziris N; Tzeli D; Demetzos C; Valsami G; Marousis KD; Spyroulias GA; Mavromoustakos T Molecules; 2022 Apr; 27(8):. PubMed ID: 35458617 [TBL] [Abstract][Full Text] [Related]
5. Development of morin/hydroxypropyl-β-cyclodextrin inclusion complex: Enhancement of bioavailability, antihyperalgesic and anti-inflammatory effects. Lima BDS; Campos CA; da Silva Santos ACR; Santos VCN; Trindade GDGG; Shanmugam S; Pereira EWM; Marreto RN; Duarte MC; Almeida JRGDS; Quintans JSS; Quintans LJ; Araújo AAS Food Chem Toxicol; 2019 Apr; 126():15-24. PubMed ID: 30738132 [TBL] [Abstract][Full Text] [Related]
6. Preparation of curcumin-hydroxypropyl-β-cyclodextrin inclusion complex by cosolvency-lyophilization procedure to enhance oral bioavailability of the drug. Li N; Wang N; Wu T; Qiu C; Wang X; Jiang S; Zhang Z; Liu T; Wei C; Wang T Drug Dev Ind Pharm; 2018 Dec; 44(12):1966-1974. PubMed ID: 30059244 [TBL] [Abstract][Full Text] [Related]
7. Elucidation of the orientation of selected drugs with 2-hydroxylpropyl-β-cyclodextrin using 2D-NMR spectroscopy and molecular modeling. Adhikari S; Daftardar S; Fratev F; Rivera M; Sirimulla S; Alexander K; Boddu SHS Int J Pharm; 2018 Jul; 545(1-2):357-365. PubMed ID: 29747001 [TBL] [Abstract][Full Text] [Related]
8. Cyclodextrin Complexed Lipid Nanoparticles of Irbesartan for Oral Applications: Design, Development, and In Vitro Characterization. Dudhipala N; Ettireddy S; Youssef AAA; Puchchakayala G Molecules; 2021 Dec; 26(24):. PubMed ID: 34946619 [TBL] [Abstract][Full Text] [Related]
9. Solubility Enhancement of Myricetin by Inclusion Complexation with Heptakis- Han D; Han Z; Liu L; Wang Y; Xin S; Zhang H; Yu Z Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31991574 [TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo studies on the complexes of vinpocetine with hydroxypropyl-beta-cyclodextrin. Nie S; Fan X; Peng Y; Yang X; Wang C; Pan W Arch Pharm Res; 2007 Aug; 30(8):991-1001. PubMed ID: 17879753 [TBL] [Abstract][Full Text] [Related]
11. Host-Guest Interactions between Candesartan and Its Prodrug Candesartan Cilexetil in Complex with 2-Hydroxypropyl-β-cyclodextrin: On the Biological Potency for Angiotensin II Antagonism. Ntountaniotis D; Andreadelis I; Kellici TF; Karageorgos V; Leonis G; Christodoulou E; Kiriakidi S; Becker-Baldus J; Stylos EK; Chatziathanasiadou MV; Chatzigiannis CM; Damalas DE; Aksoydan B; Javornik U; Valsami G; Glaubitz C; Durdagi S; Thomaidis NS; Kolocouris A; Plavec J; Tzakos AG; Liapakis G; Mavromoustakos T Mol Pharm; 2019 Mar; 16(3):1255-1271. PubMed ID: 30681344 [TBL] [Abstract][Full Text] [Related]
12. Spray-dried mucoadhesive microparticles based on S-protected thiolated hydroxypropyl-β-cyclodextrin for budesonide nasal delivery. Racaniello GF; Laquintana V; Summonte S; Lopedota A; Cutrignelli A; Lopalco A; Franco M; Bernkop-Schnürch A; Denora N Int J Pharm; 2021 Jun; 603():120728. PubMed ID: 34029665 [TBL] [Abstract][Full Text] [Related]
13. Preparation, characterization and in vivo evaluation of a formulation of dantrolene sodium with hydroxypropyl-β-cyclodextrin. Chen M; Wu Q; Jiang J; Jin X; Liu S; Wang M; Zhao C J Pharm Biomed Anal; 2017 Feb; 135():153-159. PubMed ID: 28027523 [TBL] [Abstract][Full Text] [Related]
15. The effect of pH and triethanolamine on sulfisoxazole complexation with hydroxypropyl-beta-cyclodextrin. Gladys G; Claudia G; Marcela L Eur J Pharm Sci; 2003 Nov; 20(3):285-93. PubMed ID: 14592694 [TBL] [Abstract][Full Text] [Related]
16. Inclusion Complexation of Etodolac with Hydroxypropyl-beta-cyclodextrin and Auxiliary Agents: Formulation Characterization and Molecular Modeling Studies. Sherje AP; Kulkarni V; Murahari M; Nayak UY; Bhat P; Suvarna V; Dravyakar B Mol Pharm; 2017 Apr; 14(4):1231-1242. PubMed ID: 28248111 [TBL] [Abstract][Full Text] [Related]
17. Comparative muscle irritation and pharmacokinetics of florfenicol-hydroxypropyl-β-cyclodextrin inclusion complex freeze-dried powder injection and florfenicol commercial injection in beagle dogs. Fan G; Zhang L; Shen Y; Shu G; Yuan Z; Lin J; Zhang W; Peng G; Zhong Z; Yin L; Fu H Sci Rep; 2019 Nov; 9(1):16739. PubMed ID: 31723173 [TBL] [Abstract][Full Text] [Related]
18. Inclusion complexes of tea polyphenols with HP-β-cyclodextrin:Preparation, characterization, molecular docking, and antioxidant activity. Zhong Y; Li W; Ran L; Hou R; Han P; Lu S; Wang Q; Zhao W; Zhu Y; Dong J J Food Sci; 2020 Apr; 85(4):1105-1113. PubMed ID: 32175596 [TBL] [Abstract][Full Text] [Related]
19. Preparation, characterization and in vivo evaluation of formulation of repaglinide with hydroxypropyl-β-cyclodextrin. Liu M; Cao W; Sun Y; He Z Int J Pharm; 2014 Dec; 477(1-2):159-66. PubMed ID: 25455768 [TBL] [Abstract][Full Text] [Related]
20. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation. Badr-Eldin SM; Elkheshen SA; Ghorab MM Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]